IE
COGT icon

Israel Englander’s Cogent Biosciences COGT Stock Holding History

Israel Englander’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,000
Closed -$3.55M – 5805
2025
Q4 		$3.55M Sell
100,000
-90,100
-47% -$2.53M ﹤0.01% 3387
2025
Q3 		$2.73M Buy
190,100
+113,200
+147% +$1.34M ﹤0.01% 3754
2025
Q2 		$552K Buy
76,900
+26,900
+54% +$149K ﹤0.01% 4839
2025
Q1 		$300K Sell
50,000
-50,000
-50% -$392K ﹤0.01% 5103
2024
Q4 		$780K Buy
+100,000
New +$997K ﹤0.01% 4399
2024
Q3 		– Sell
-29,100
Closed -$245K – 6143
2024
Q2 		$245K Sell
29,100
-49,400
-63% -$375K ﹤0.01% 5027
2024
Q1 		$528K Buy
+78,500
New +$485K ﹤0.01% 4772

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Israel Englander's COGT Position: Q2 2026 in Review

Israel Englander reduced its Cogent Biosciences (COGT) stake by 24% in Q2 2026, selling an estimated $9.96M and leaving 907,712 shares worth $35.1M. The position accounts for 0.01% of the portfolio, ranked #1149.

Israel Englander first reported a position in COGT in Q1 2018 and has held it in 28 quarters since. The position peaked at $45.9M in Q1 2026. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Israel Englander held 907,712 shares of Cogent Biosciences worth $35.1M as of Q2 2026.
  • Israel Englander sold 284,694 Cogent Biosciences shares in Q2 2026, an estimated $9.96M.
  • Cogent Biosciences made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1149 holding.
  • Israel Englander first reported a position in Cogent Biosciences in Q1 2018 and has held it in 28 quarters since.
  • Israel Englander's Cogent Biosciences position peaked at $45.9M in Q1 2026.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.